Key Highlights
- On June 10, ARK Invest offloaded 89,915 Robinhood shares valued at $7.53 million as the stock surged past $90
- The investment firm also divested 186,720 Iridium Communications shares worth $8.42 million in an ongoing position trim
- ARK’s primary acquisition was Kodiak AI, purchasing 141,502 shares totaling $868,822
- Robinhood board member Meyer Malka accumulated more than $50 million worth of shares recently, demonstrating strong insider conviction
- Wall Street analysts maintain a Strong Buy rating on Robinhood with a consensus target of $99.56
Cathie Wood’s ARK Invest executed multiple portfolio adjustments on June 10, 2026. The investment management firm reduced positions in Robinhood Markets, Iridium Communications, and Veracyte, while simultaneously expanding its stake in Kodiak AI.
These transactions represent part of ARK’s continuous portfolio optimization strategy focused on disruptive innovation companies.
ARK’s Robinhood Divestment
On June 10, ARK divested 89,915 Robinhood shares, generating approximately $7.53 million in proceeds. The transaction occurred as Robinhood’s stock price pushed beyond $90 during morning trading sessions, continuing its impressive upward momentum.
Robinhood continues demonstrating robust operational performance. The financial technology platform disclosed that aggregate platform assets increased 9% month-over-month in May.
CEO Vlad Tenev revealed significant news that Robinhood Securities secured regulatory clearance to serve as an IPO underwriter. This milestone opens up additional revenue streams through underwriting fees.
ARK’s divestment seems strategic profit-taking rather than fundamental pessimism. Insider transactions paint an optimistic picture — board director Meyer Malka, who founded Ribbit Capital, acquired approximately $20.18 million in Robinhood stock on June 5 exclusively.
Malka’s aggregate share purchases throughout the past week surpassed $50 million. Such substantial insider accumulation typically indicates robust confidence in the company’s future trajectory.
According to TipRanks data, Robinhood maintains a Strong Buy consensus from analysts, with 15 Buy recommendations and 3 Hold ratings. The consensus price target of $99.56 suggests approximately 15% potential upside from present levels.
Iridium Reduction and Kodiak AI Accumulation
ARK’s most significant transaction by dollar value on June 10 was divesting Iridium Communications holdings. The firm liquidated 186,720 shares, generating $8.42 million in proceeds. This extended a divestment pattern from the previous trading session, indicating a calculated position reduction.
ARK additionally offloaded 143,385 Veracyte shares for $7.06 million. This continues a week-long pattern of decreasing exposure to the genomic diagnostics specialist.
Regarding purchases, Kodiak AI dominated ARK’s buying activity. The firm acquired 141,502 shares totaling $868,822. This purchase aligns with recent Kodiak AI accumulation patterns across ARK’s exchange-traded fund portfolio.
Additional minor dispositions included Roku, Twist Bioscience, Strata Critical Medical, 10X Genomics, Cerus, Pacific Biosciences, and Recursion Pharmaceuticals. Each of these transactions remained below $1.7 million individually.
These portfolio adjustments demonstrate ARK’s persistent approach of rotating capital from certain holdings while establishing positions in enterprises aligned with transformative technology sectors.
Robinhood’s IPO underwriting authorization and expanding platform assets position it as a company attracting significant analyst attention as 2026’s second half approaches.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
